- Patients must have met the inclusion criteria for the preceding fibromyalgia Study
A0081180, and have received pregabalin/placebo under double-blind conditions.
- Patients may not participate in the study if they experienced a serious adverse event
during the previous fibromyalgia study A0081180 which was determined to be related to
the study medication by the investigator or sponsor.